Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL

Published Date: 21 Jun 2024

Undetectable MRD rates of 90% or higher, PFS of 7 years or more

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Analysis of NRG trial in limited-stage small cell lung cancer suggests QOL benefit with twice- vs. once-daily radiation

2.

a brand-new generic therapy for different types of cancer.

3.

Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.

4.

Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.

5.

ALK Inhibitor Shows Promise in Rare, Progressive Tumor Types


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot